CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
64.45
-4.19 (-6.10%)
Mar 18, 2026, 4:00 PM EDT - Market closed
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $5.44 billion as of March 18, 2026. Its market cap has increased by 184.79% in one year.
Market Cap
5.44B
Enterprise Value
4.71B
1-Year Change
184.79%
Ranking
Category
Stock Price
$64.45
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $5.44B, an increase of 351.17%. That is a compound annual growth rate of 102.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 5.80B | 73.04% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.50B |
| Rhythm Pharmaceuticals | 6.18B |
| Protagonist Therapeutics | 6.17B |
| Cogent Biosciences | 5.79B |
| Mirum Pharmaceuticals | 5.59B |
| PTC Therapeutics | 5.53B |
| Caris Life Sciences | 5.38B |
| Celcuity | 5.32B |